AnaptysBio, Inc. (ANAB) has a MoatMap StockRank of 55/100 based on Quality (58/100), Value (17/100), and Momentum (66/100) factor scores. The current signal is HOLD. As a healthcare company, there is no direct and obvious macro tailwind from the identified themes creating an asymmetric opportunity, and insufficient information to assess its quality as a compounder.